Author: Daniel snow
A new study finds 51 percent of modest-sized companies are still tentative about using AI to automate work tasks. Source link
Amazon CEO Andy Jassy speaks during a keynote address at AWS re:Invent 2024, a conference hosted by Amazon Web Services, at The Venetian Las Vegas on December 3, 2024 in Las Vegas, Nevada.Noah Berger | Getty ImagesAmazon CEO Andy Jassy said Tuesday that the company’s corporate workforce will shrink in the coming years as it adopts more generative artificial intelligence tools and agents.”We will need fewer people doing some of the jobs that are being done today, and more people doing other types of jobs,” Jassy said in a memo to employees. “It’s hard to know exactly where this nets…
The company’s much-anticipated annual sales event will take place in July. Source link
Annuities are a better deal now than even a few years ago. So why aren’t people buying them? Source link
Club name Eli Lilly will be riding the obesity-drug wave for years to come, but the world’s most valuable health-care company is not forgetting to stock its pipeline with other potential winners. The latest bit of evidence: Eli Lilly on Tuesday announced plans to buy gene-editing firm Verve Therapeutics for as much as $1.3 billion — its third small deal of the year. It comes just weeks after Lilly said it was buying pain-focused biotech SiteOne Therapeutics for up to $1 billion. In January, Lilly bought an experimental breast cancer drug from Scorpion Therapeutics for up to $2.5 billion. Lilly’s…
If the administration’s tariff policy is meant to increase domestic manufacturing jobs, Keen’s Kentucky plant may be a wake-up call. Source link
Tariffs aren’t yet showing up in inflation data, but that doesn’t mean they won’t in the coming months, says Richard Clarida, a former Federal Reserve Vice Chair and now an economic adviser at Pimco Source link
Antibody drug conjugates (ADCs) are targeted medicines that deliver chemotherapy agents to cancer cells 3d renderingLove Employee | Istock | Getty ImagesChemotherapy has long been a cornerstone of cancer treatment, saving millions of lives.But the pharmaceutical industry says a popular class of targeted cancer therapies could one day replace chemotherapy and its potential for harsh side effects in some cases. Antibody-drug conjugates (ADCs) have taken major strides in recent years, as companies including AstraZeneca, Daiichi Sankyo, Pfizer and Merck are developing drugs in the space that could ease the trials of cancer treatment and make them big money in the…
AI is coming to steal people’s jobs, computing sage Geoffrey Hinton says. Many white-collar workers should be worried sooner than most. Source link
Netflix is moving into the theme-park space with the opening of Netflix House in Philadelphia and Dallas later this year. Source link